Global Systemic Lupus Erythematous SLE Drug Industry Growth and Trends Forecast to 2032

Types

• BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS)
• Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
• Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
• Anticoagulants
• Antimalarials
• Immunosuppressive Agents/Immune Modulators
• Corticosteroids
• Anti-Inflammatories

Applications

• Topical
• Oral
• Intravenous
• Others

Key Companies